stopping glp 1 cold turkey GLP-1 Series: What Happens When You Quit? Wegovy: why half the people

Lancet 401 , 18111821 (2023)

Some patients express concern about injectable therapies, but GLP-1 injectors are typically very well tolerated and easy to use

Professor Alejandra Tomas Catala, lead author and Head of Section of Cell Biology and Functional Genomics in the Department of Metabolism, Digestion and Reproduction, said: Our study reveals an entirely new way in which GLP-1 receptor agonists protect pancreatic -cells

Clinical trial data shows that burping rates vary by drug and dose: Ozempic injection (semaglutide): Burping reported in 3% of patients at the 0.5 mg dose and 1% of patients at the 1 mg dose Wegovy injection (semaglutide): Burping reported in 7% of adults at the 2.4 mg dose Mounjaro and Zepbound (tirzepatide): Burping reported in 25% of patients across doses (Source: Drugs.com) These numbers likely underestimate real-world prevalence, as sulfur burps are often underreported in clinical trials or described under broader terms like belching or eructation. Some patients avoid mentioning it to their doctors out of embarrassment, as well